COMP <GO>
CAI vs OSCR // NET PROFIT MARGIN
Caris Life Sciences Inc. (NASDAQ) VS. Oscar Health Inc. (NYSE) • 15-METRIC TALLY: CAI 9
— OSCR 2
▲ NET PROFIT MARGIN LEADER: CAI
LAST: $32.10 (-6.50%) • MKT CAP: $9.70B
net-margins
-8.40%
LAST: $31.00 (+2.07%) • MKT CAP: $9.37B
net-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CAI VS. OSCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CAI | OSCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.40% | -35.00% | +39.40 | CAI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.65% | 11.51% | -10.86 | OSCR | /fcf-yield <GO> |
| Operating Margin | 5.60% | -60.00% | +65.60 | CAI | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -8.40% | -60.00% | +51.60 | CAI | /net-margins <GO> |
| Revenue Growth (YoY) | 97.00% | 39.00% | +58.00 | CAI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.79 | 0.45 | +9.34 | CAI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | CAI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.8 | 41.9 | +16.90 | CAI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.97 | -0.06 | OSCR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 23.0x | -2.00 | CAI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.70B | $9.37B | $327.9M | CAI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CAI REV | OSCR REV | CAI GROSS % | OSCR GROSS % | CAI FCF | OSCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $812.0M | $28.6M | — | — | $66.9M | $1.09B |
| FY 2024 | $412.3M | $20.6M | — | — | -$253.6M | $977.3M |
| FY 2023 | $306.1M | $21.4M | — | — | -$289.9M | -$273.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CAI // BETA 0.91
OSCR // BETA 0.97